Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found. None of the 1,456 healthcare workers at Oxford University Hospitals (OUH) NHS Foundation Trust who had received two vaccines had a symptomatic infection […]
The final analyses for this trial were published on 11 March – please see the full release Novavax UK and SA Final Data Announcement March 11 2021 FINAL[87]
In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for […]
The Nuffield Orthopaedic Centre (NOC) in Oxford has been rated highly for how it uses technology to improve patient care. Oxford University Hospitals NHS Foundation Trust, which runs the hospital, has reached ‘Stage 6’ on the EMR Adoption and Maturity (EMRAM) scale, the second highest rating by the international Healthcare Information and Management Systems Society (HIMSS). HIMSS is […]
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage. Research by Oxford and Sheffield Universities is the first in Europe to use hyperpolarised xenon gas with MRI scanning to identify the impact on lung function as patients […]
This is not a true blog but we use this area to post updates and information about the great work and activities of our partners in the Oxford Academic Health Partnership: Oxford Brookes University Oxford Health NHS FT Oxford University Hospitals NHS FT University of Oxford and Medical Sciences Division Oxford Academic Health Science Network […]
Oxford Structural Genomics Consortium (SGC) is a key member of a new EUbOPEN consortium which has been awarded funding from the Innovative Medicines Initiative to develop openly available chemical tools for understanding human biology. The Oxford Structural Genomics Consortium (SGC) is a key member of a new consortium, “Enabling and Unlocking biology in the Open” (EUbOPEN), which […]